Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISEDRONATE vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISEDRONATE vs RITUXIMAB: Safety Overview

Metric RISEDRONATE RITUXIMAB
Total FAERS Reports 6,768 178,614
Deaths Reported 202 28,910
Death Rate 3.0% 16.2%
Hospitalizations 1,825 54,631
Average Patient Age 68.0 yrs 54.6 yrs
% Female Patients 92.3% 64.3%
FDA Approval Date Apr 14, 2000 N/A
Manufacturer Aurobindo Pharma Limited Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription